Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.
Identifieur interne : 003B59 ( Ncbi/Merge ); précédent : 003B58; suivant : 003B60Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.
Auteurs : E. Van Den Neste [Belgique] ; N. Schmitz [Allemagne] ; N. Mounier [France] ; D. Gill [Australie] ; D. Linch [Royaume-Uni] ; M. Trneny [République tchèque] ; R. Bouadballah [France] ; J. Radford [Royaume-Uni] ; M. Bargetzi [Suisse] ; V. Ribrag [France] ; U. Dührsen [Allemagne] ; D. Ma [Australie] ; J. Briere [France] ; C. Thieblemont [France] ; E. Bachy [France] ; C H Moskowitz [États-Unis] ; B. Glass [Allemagne] ; C. Gisselbrecht [France]Source :
- Bone marrow transplantation [ 1476-5365 ] ; 2017.
Abstract
In the CORAL study, 255 chemosensitive relapses with diffuse large B-cell lymphoma (DLBCL) were consolidated with autologous stem cell transplantation (ASCT), and 75 of them relapsed thereafter. The median time between ASCT and progression was 7.1 months. The median age was 56.1 years; tertiary International Prognosis Index (tIPI) observed at relapse was 0-2 in 71.6% of the patients and >2 in 28.4%. The overall response rate to third-line chemotherapy was 44%. The median overall survival (OS) was 10.0 months (median follow-up: 32.8 months). Thirteen patients received an allogeneic SCT, and three a second ASCT. The median OS was shorter among patients who relapsed <6 months (5.7 months) compared with those relapsing ⩾12 months after ASCT (12.6 months, P=0.0221). The median OS in patients achieving CR, PR or no response after the third-line regimen was 37.7 (P<0.0001), 10.0 (P=0.03) and 6.3 months, respectively. The median OS varied according to tIPI: 0-2: 12.6 months and >2: 5.3 months (P=0.0007). In multivariate analysis, tIPI >2, achievement of response and remission lasting <6 months predicted the OS. This report identifies the prognostic factors for DLBCL relapsing after ASCT and thus helps to select patients for experimental therapy.
DOI: 10.1038/bmt.2016.213
PubMed: 27643872
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001119
- to stream PubMed, to step Curation: 001116
- to stream PubMed, to step Checkpoint: 001116
Links to Exploration step
pubmed:27643872Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.</title><author><name sortKey="Van Den Neste, E" sort="Van Den Neste, E" uniqKey="Van Den Neste E" first="E" last="Van Den Neste">E. Van Den Neste</name><affiliation wicri:level="3"><nlm:affiliation>Cliniques Universitaires UCL Saint-Luc, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Cliniques Universitaires UCL Saint-Luc, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Schmitz, N" sort="Schmitz, N" uniqKey="Schmitz N" first="N" last="Schmitz">N. Schmitz</name><affiliation wicri:level="3"><nlm:affiliation>AsklepiosKlinik St Georg, AbteilungHämatologie und Stammzelltransplantation, Hamburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>AsklepiosKlinik St Georg, AbteilungHämatologie und Stammzelltransplantation, Hamburg</wicri:regionArea><placeName><settlement type="city">Hambourg</settlement><region type="land" nuts="2">Hambourg</region></placeName></affiliation></author><author><name sortKey="Mounier, N" sort="Mounier, N" uniqKey="Mounier N" first="N" last="Mounier">N. Mounier</name><affiliation wicri:level="3"><nlm:affiliation>CHU de l'Archet, route de St Antoine-Ginestiere, Nice, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHU de l'Archet, route de St Antoine-Ginestiere, Nice</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Nice</settlement></placeName></affiliation></author><author><name sortKey="Gill, D" sort="Gill, D" uniqKey="Gill D" first="D" last="Gill">D. Gill</name><affiliation wicri:level="1"><nlm:affiliation>Princess Alexandra Hospital, Woodville, South Australia, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Princess Alexandra Hospital, Woodville, South Australia</wicri:regionArea><wicri:noRegion>South Australia</wicri:noRegion></affiliation></author><author><name sortKey="Linch, D" sort="Linch, D" uniqKey="Linch D" first="D" last="Linch">D. Linch</name><affiliation wicri:level="4"><nlm:affiliation>University College London, Cancer Institute, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University College London, Cancer Institute, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Trneny, M" sort="Trneny, M" uniqKey="Trneny M" first="M" last="Trneny">M. Trneny</name><affiliation wicri:level="3"><nlm:affiliation>Charles University and General Hospital, Praha, Czech Republic.</nlm:affiliation><country xml:lang="fr">République tchèque</country><wicri:regionArea>Charles University and General Hospital, Praha</wicri:regionArea><placeName><settlement type="city">Prague</settlement><region type="région" nuts="2">Bohême centrale</region></placeName></affiliation></author><author><name sortKey="Bouadballah, R" sort="Bouadballah, R" uniqKey="Bouadballah R" first="R" last="Bouadballah">R. Bouadballah</name><affiliation wicri:level="3"><nlm:affiliation>Institut Paoli Calmette Département d'Onco-Hématologie, Institut Paoli-Calmettes, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Paoli Calmette Département d'Onco-Hématologie, Institut Paoli-Calmettes, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName></affiliation></author><author><name sortKey="Radford, J" sort="Radford, J" uniqKey="Radford J" first="J" last="Radford">J. Radford</name><affiliation wicri:level="3"><nlm:affiliation>University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester</wicri:regionArea><placeName><settlement type="city">Manchester</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Manchester</region></placeName></affiliation></author><author><name sortKey="Bargetzi, M" sort="Bargetzi, M" uniqKey="Bargetzi M" first="M" last="Bargetzi">M. Bargetzi</name><affiliation wicri:level="1"><nlm:affiliation>Hämatologie, Kantonsspital Aarau, Aarau, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Hämatologie, Kantonsspital Aarau, Aarau</wicri:regionArea><wicri:noRegion>Aarau</wicri:noRegion></affiliation></author><author><name sortKey="Ribrag, V" sort="Ribrag, V" uniqKey="Ribrag V" first="V" last="Ribrag">V. Ribrag</name><affiliation wicri:level="1"><nlm:affiliation>Institut Gustave Roussy, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Gustave Roussy, Villejuif</wicri:regionArea><wicri:noRegion>Villejuif</wicri:noRegion><wicri:noRegion>Villejuif</wicri:noRegion></affiliation></author><author><name sortKey="Duhrsen, U" sort="Duhrsen, U" uniqKey="Duhrsen U" first="U" last="Dührsen">U. Dührsen</name><affiliation wicri:level="1"><nlm:affiliation>Universitätsklinikum Essen, KlinikfürHämatologie-Hufelandstraße, Essen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Universitätsklinikum Essen, KlinikfürHämatologie-Hufelandstraße, Essen</wicri:regionArea><wicri:noRegion>Essen</wicri:noRegion><wicri:noRegion>Essen</wicri:noRegion><wicri:noRegion>Essen</wicri:noRegion></affiliation></author><author><name sortKey="Ma, D" sort="Ma, D" uniqKey="Ma D" first="D" last="Ma">D. Ma</name><affiliation wicri:level="1"><nlm:affiliation>St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>St Vincent's Hospital Sydney, Darlinghurst, NSW</wicri:regionArea><wicri:noRegion>NSW</wicri:noRegion></affiliation></author><author><name sortKey="Briere, J" sort="Briere, J" uniqKey="Briere J" first="J" last="Briere">J. Briere</name><affiliation wicri:level="3"><nlm:affiliation>Hopital Saint Louis Paris, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hopital Saint Louis Paris, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Thieblemont, C" sort="Thieblemont, C" uniqKey="Thieblemont C" first="C" last="Thieblemont">C. Thieblemont</name><affiliation wicri:level="3"><nlm:affiliation>Hopital Saint Louis Paris, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hopital Saint Louis Paris, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Bachy, E" sort="Bachy, E" uniqKey="Bachy E" first="E" last="Bachy">E. Bachy</name><affiliation wicri:level="1"><nlm:affiliation>Hospices Civils de Lyon, Université de Lyon, Pierre Benite, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hospices Civils de Lyon, Université de Lyon, Pierre Benite</wicri:regionArea><wicri:noRegion>Pierre Benite</wicri:noRegion><wicri:noRegion>Pierre Benite</wicri:noRegion></affiliation></author><author><name sortKey="Moskowitz, C H" sort="Moskowitz, C H" uniqKey="Moskowitz C" first="C H" last="Moskowitz">C H Moskowitz</name><affiliation wicri:level="2"><nlm:affiliation>Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Glass, B" sort="Glass, B" uniqKey="Glass B" first="B" last="Glass">B. Glass</name><affiliation wicri:level="3"><nlm:affiliation>AsklepiosKlinik St Georg, AbteilungHämatologie und Stammzelltransplantation, Hamburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>AsklepiosKlinik St Georg, AbteilungHämatologie und Stammzelltransplantation, Hamburg</wicri:regionArea><placeName><settlement type="city">Hambourg</settlement><region type="land" nuts="2">Hambourg</region></placeName></affiliation></author><author><name sortKey="Gisselbrecht, C" sort="Gisselbrecht, C" uniqKey="Gisselbrecht C" first="C" last="Gisselbrecht">C. Gisselbrecht</name><affiliation wicri:level="3"><nlm:affiliation>Hopital Saint Louis Paris, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hopital Saint Louis Paris, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27643872</idno><idno type="pmid">27643872</idno><idno type="doi">10.1038/bmt.2016.213</idno><idno type="wicri:Area/PubMed/Corpus">001119</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001119</idno><idno type="wicri:Area/PubMed/Curation">001116</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001116</idno><idno type="wicri:Area/PubMed/Checkpoint">001116</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001116</idno><idno type="wicri:Area/Ncbi/Merge">003B59</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.</title><author><name sortKey="Van Den Neste, E" sort="Van Den Neste, E" uniqKey="Van Den Neste E" first="E" last="Van Den Neste">E. Van Den Neste</name><affiliation wicri:level="3"><nlm:affiliation>Cliniques Universitaires UCL Saint-Luc, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Cliniques Universitaires UCL Saint-Luc, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Schmitz, N" sort="Schmitz, N" uniqKey="Schmitz N" first="N" last="Schmitz">N. Schmitz</name><affiliation wicri:level="3"><nlm:affiliation>AsklepiosKlinik St Georg, AbteilungHämatologie und Stammzelltransplantation, Hamburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>AsklepiosKlinik St Georg, AbteilungHämatologie und Stammzelltransplantation, Hamburg</wicri:regionArea><placeName><settlement type="city">Hambourg</settlement><region type="land" nuts="2">Hambourg</region></placeName></affiliation></author><author><name sortKey="Mounier, N" sort="Mounier, N" uniqKey="Mounier N" first="N" last="Mounier">N. Mounier</name><affiliation wicri:level="3"><nlm:affiliation>CHU de l'Archet, route de St Antoine-Ginestiere, Nice, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHU de l'Archet, route de St Antoine-Ginestiere, Nice</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Nice</settlement></placeName></affiliation></author><author><name sortKey="Gill, D" sort="Gill, D" uniqKey="Gill D" first="D" last="Gill">D. Gill</name><affiliation wicri:level="1"><nlm:affiliation>Princess Alexandra Hospital, Woodville, South Australia, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Princess Alexandra Hospital, Woodville, South Australia</wicri:regionArea><wicri:noRegion>South Australia</wicri:noRegion></affiliation></author><author><name sortKey="Linch, D" sort="Linch, D" uniqKey="Linch D" first="D" last="Linch">D. Linch</name><affiliation wicri:level="4"><nlm:affiliation>University College London, Cancer Institute, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University College London, Cancer Institute, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Trneny, M" sort="Trneny, M" uniqKey="Trneny M" first="M" last="Trneny">M. Trneny</name><affiliation wicri:level="3"><nlm:affiliation>Charles University and General Hospital, Praha, Czech Republic.</nlm:affiliation><country xml:lang="fr">République tchèque</country><wicri:regionArea>Charles University and General Hospital, Praha</wicri:regionArea><placeName><settlement type="city">Prague</settlement><region type="région" nuts="2">Bohême centrale</region></placeName></affiliation></author><author><name sortKey="Bouadballah, R" sort="Bouadballah, R" uniqKey="Bouadballah R" first="R" last="Bouadballah">R. Bouadballah</name><affiliation wicri:level="3"><nlm:affiliation>Institut Paoli Calmette Département d'Onco-Hématologie, Institut Paoli-Calmettes, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Paoli Calmette Département d'Onco-Hématologie, Institut Paoli-Calmettes, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName></affiliation></author><author><name sortKey="Radford, J" sort="Radford, J" uniqKey="Radford J" first="J" last="Radford">J. Radford</name><affiliation wicri:level="3"><nlm:affiliation>University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester</wicri:regionArea><placeName><settlement type="city">Manchester</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Manchester</region></placeName></affiliation></author><author><name sortKey="Bargetzi, M" sort="Bargetzi, M" uniqKey="Bargetzi M" first="M" last="Bargetzi">M. Bargetzi</name><affiliation wicri:level="1"><nlm:affiliation>Hämatologie, Kantonsspital Aarau, Aarau, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Hämatologie, Kantonsspital Aarau, Aarau</wicri:regionArea><wicri:noRegion>Aarau</wicri:noRegion></affiliation></author><author><name sortKey="Ribrag, V" sort="Ribrag, V" uniqKey="Ribrag V" first="V" last="Ribrag">V. Ribrag</name><affiliation wicri:level="1"><nlm:affiliation>Institut Gustave Roussy, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Gustave Roussy, Villejuif</wicri:regionArea><wicri:noRegion>Villejuif</wicri:noRegion><wicri:noRegion>Villejuif</wicri:noRegion></affiliation></author><author><name sortKey="Duhrsen, U" sort="Duhrsen, U" uniqKey="Duhrsen U" first="U" last="Dührsen">U. Dührsen</name><affiliation wicri:level="1"><nlm:affiliation>Universitätsklinikum Essen, KlinikfürHämatologie-Hufelandstraße, Essen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Universitätsklinikum Essen, KlinikfürHämatologie-Hufelandstraße, Essen</wicri:regionArea><wicri:noRegion>Essen</wicri:noRegion><wicri:noRegion>Essen</wicri:noRegion><wicri:noRegion>Essen</wicri:noRegion></affiliation></author><author><name sortKey="Ma, D" sort="Ma, D" uniqKey="Ma D" first="D" last="Ma">D. Ma</name><affiliation wicri:level="1"><nlm:affiliation>St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>St Vincent's Hospital Sydney, Darlinghurst, NSW</wicri:regionArea><wicri:noRegion>NSW</wicri:noRegion></affiliation></author><author><name sortKey="Briere, J" sort="Briere, J" uniqKey="Briere J" first="J" last="Briere">J. Briere</name><affiliation wicri:level="3"><nlm:affiliation>Hopital Saint Louis Paris, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hopital Saint Louis Paris, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Thieblemont, C" sort="Thieblemont, C" uniqKey="Thieblemont C" first="C" last="Thieblemont">C. Thieblemont</name><affiliation wicri:level="3"><nlm:affiliation>Hopital Saint Louis Paris, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hopital Saint Louis Paris, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Bachy, E" sort="Bachy, E" uniqKey="Bachy E" first="E" last="Bachy">E. Bachy</name><affiliation wicri:level="1"><nlm:affiliation>Hospices Civils de Lyon, Université de Lyon, Pierre Benite, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hospices Civils de Lyon, Université de Lyon, Pierre Benite</wicri:regionArea><wicri:noRegion>Pierre Benite</wicri:noRegion><wicri:noRegion>Pierre Benite</wicri:noRegion></affiliation></author><author><name sortKey="Moskowitz, C H" sort="Moskowitz, C H" uniqKey="Moskowitz C" first="C H" last="Moskowitz">C H Moskowitz</name><affiliation wicri:level="2"><nlm:affiliation>Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Glass, B" sort="Glass, B" uniqKey="Glass B" first="B" last="Glass">B. Glass</name><affiliation wicri:level="3"><nlm:affiliation>AsklepiosKlinik St Georg, AbteilungHämatologie und Stammzelltransplantation, Hamburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>AsklepiosKlinik St Georg, AbteilungHämatologie und Stammzelltransplantation, Hamburg</wicri:regionArea><placeName><settlement type="city">Hambourg</settlement><region type="land" nuts="2">Hambourg</region></placeName></affiliation></author><author><name sortKey="Gisselbrecht, C" sort="Gisselbrecht, C" uniqKey="Gisselbrecht C" first="C" last="Gisselbrecht">C. Gisselbrecht</name><affiliation wicri:level="3"><nlm:affiliation>Hopital Saint Louis Paris, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hopital Saint Louis Paris, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><series><title level="j">Bone marrow transplantation</title><idno type="eISSN">1476-5365</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In the CORAL study, 255 chemosensitive relapses with diffuse large B-cell lymphoma (DLBCL) were consolidated with autologous stem cell transplantation (ASCT), and 75 of them relapsed thereafter. The median time between ASCT and progression was 7.1 months. The median age was 56.1 years; tertiary International Prognosis Index (tIPI) observed at relapse was 0-2 in 71.6% of the patients and >2 in 28.4%. The overall response rate to third-line chemotherapy was 44%. The median overall survival (OS) was 10.0 months (median follow-up: 32.8 months). Thirteen patients received an allogeneic SCT, and three a second ASCT. The median OS was shorter among patients who relapsed <6 months (5.7 months) compared with those relapsing ⩾12 months after ASCT (12.6 months, P=0.0221). The median OS in patients achieving CR, PR or no response after the third-line regimen was 37.7 (P<0.0001), 10.0 (P=0.03) and 6.3 months, respectively. The median OS varied according to tIPI: 0-2: 12.6 months and >2: 5.3 months (P=0.0007). In multivariate analysis, tIPI >2, achievement of response and remission lasting <6 months predicted the OS. This report identifies the prognostic factors for DLBCL relapsing after ASCT and thus helps to select patients for experimental therapy.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">27643872</PMID><DateCreated><Year>2016</Year><Month>09</Month><Day>19</Day></DateCreated><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5365</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Bone marrow transplantation</Title><ISOAbbreviation>Bone Marrow Transplant.</ISOAbbreviation></Journal><ArticleTitle>Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.</ArticleTitle><Pagination><MedlinePgn>216-221</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/bmt.2016.213</ELocationID><Abstract><AbstractText>In the CORAL study, 255 chemosensitive relapses with diffuse large B-cell lymphoma (DLBCL) were consolidated with autologous stem cell transplantation (ASCT), and 75 of them relapsed thereafter. The median time between ASCT and progression was 7.1 months. The median age was 56.1 years; tertiary International Prognosis Index (tIPI) observed at relapse was 0-2 in 71.6% of the patients and >2 in 28.4%. The overall response rate to third-line chemotherapy was 44%. The median overall survival (OS) was 10.0 months (median follow-up: 32.8 months). Thirteen patients received an allogeneic SCT, and three a second ASCT. The median OS was shorter among patients who relapsed <6 months (5.7 months) compared with those relapsing ⩾12 months after ASCT (12.6 months, P=0.0221). The median OS in patients achieving CR, PR or no response after the third-line regimen was 37.7 (P<0.0001), 10.0 (P=0.03) and 6.3 months, respectively. The median OS varied according to tIPI: 0-2: 12.6 months and >2: 5.3 months (P=0.0007). In multivariate analysis, tIPI >2, achievement of response and remission lasting <6 months predicted the OS. This report identifies the prognostic factors for DLBCL relapsing after ASCT and thus helps to select patients for experimental therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Van Den Neste</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cliniques Universitaires UCL Saint-Luc, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitz</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>AsklepiosKlinik St Georg, AbteilungHämatologie und Stammzelltransplantation, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mounier</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>CHU de l'Archet, route de St Antoine-Ginestiere, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gill</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Princess Alexandra Hospital, Woodville, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linch</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University College London, Cancer Institute, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trneny</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Charles University and General Hospital, Praha, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouadballah</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institut Paoli Calmette Département d'Onco-Hématologie, Institut Paoli-Calmettes, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radford</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bargetzi</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hämatologie, Kantonsspital Aarau, Aarau, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribrag</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institut Gustave Roussy, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dührsen</LastName><ForeName>U</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Universitätsklinikum Essen, KlinikfürHämatologie-Hufelandstraße, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briere</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hopital Saint Louis Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thieblemont</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hopital Saint Louis Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bachy</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospices Civils de Lyon, Université de Lyon, Pierre Benite, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moskowitz</LastName><ForeName>C H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glass</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>AsklepiosKlinik St Georg, AbteilungHämatologie und Stammzelltransplantation, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gisselbrecht</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hopital Saint Louis Paris, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Bone Marrow Transplant</MedlineTA><NlmUniqueID>8702459</NlmUniqueID><ISSNLinking>0268-3369</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1999 Apr;17(4):1244</RefSource><PMID Version="1">10561185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2004 Jan 1;103(1):275-82</RefSource><PMID Version="1">14504078</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 Sep 20;28(27):4184-90</RefSource><PMID Version="1">20660832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2008 Nov;19(11):1935-40</RefSource><PMID Version="1">18684698</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Blood Marrow Transplant. 2010 Jan;16(1):78-85</RefSource><PMID Version="1">19744569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 Nov 15;120(20):4256-62</RefSource><PMID Version="1">23007405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 2016 Jul;174(2):235-48</RefSource><PMID Version="1">26989808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Hematol. 2014 Aug;93(8):1345-51</RefSource><PMID Version="1">24633661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2011 Apr 1;29(10):1342-8</RefSource><PMID Version="1">21321299</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2014 Jun;15(7):757-66</RefSource><PMID Version="1">24827808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bone Marrow Transplant. 2015 Oct;50(10):1286-92</RefSource><PMID Version="1">26146806</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 Dec 20;30(36):4462-9</RefSource><PMID Version="1">23091101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1992 Oct 15;80(8):2142-8</RefSource><PMID Version="1">1356515</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bone Marrow Transplant. 2016 Jan;51(1):51-7</RefSource><PMID Version="1">26367239</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer. 2015 Dec 11;14:207</RefSource><PMID Version="1">26654227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bone Marrow Transplant. 2016 Mar;51(3):365-71</RefSource><PMID Version="1">26618550</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2011 Nov 1;29(31):4079-87</RefSource><PMID Version="1">21947824</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bone Marrow Transplant. 2014 May;49(5):671-8</RefSource><PMID Version="1">24510071</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am Soc Clin Oncol Educ Book. 2015;:e449-57</RefSource><PMID Version="1">25993209</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Hematol. 2012 Jun;91(6):931-9</RefSource><PMID Version="1">22245922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 2014 Mar;164(5):668-74</RefSource><PMID Version="1">24274082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Rev Anticancer Ther. 2015 Apr;15(4):439-51</RefSource><PMID Version="1">25652253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hematol. 2013 Oct;88(10):890-4</RefSource><PMID Version="1">23813874</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>04</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>06</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>07</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27643872</ArticleId><ArticleId IdType="pii">bmt2016213</ArticleId><ArticleId IdType="doi">10.1038/bmt.2016.213</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li><li>Australie</li><li>Belgique</li><li>France</li><li>Royaume-Uni</li><li>République tchèque</li><li>Suisse</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Bohême centrale</li><li>Grand Londres</li><li>Grand Manchester</li><li>Hambourg</li><li>Provence-Alpes-Côte d'Azur</li><li>Région de Bruxelles-Capitale</li><li>État de New York</li><li>Île-de-France</li></region><settlement><li>Bruxelles</li><li>Hambourg</li><li>Londres</li><li>Manchester</li><li>Marseille</li><li>Nice</li><li>Paris</li><li>Prague</li></settlement><orgName><li>University College de Londres</li></orgName></list><tree><country name="Belgique"><region name="Région de Bruxelles-Capitale"><name sortKey="Van Den Neste, E" sort="Van Den Neste, E" uniqKey="Van Den Neste E" first="E" last="Van Den Neste">E. Van Den Neste</name></region></country><country name="Allemagne"><region name="Hambourg"><name sortKey="Schmitz, N" sort="Schmitz, N" uniqKey="Schmitz N" first="N" last="Schmitz">N. Schmitz</name></region><name sortKey="Duhrsen, U" sort="Duhrsen, U" uniqKey="Duhrsen U" first="U" last="Dührsen">U. Dührsen</name><name sortKey="Glass, B" sort="Glass, B" uniqKey="Glass B" first="B" last="Glass">B. Glass</name></country><country name="France"><region name="Provence-Alpes-Côte d'Azur"><name sortKey="Mounier, N" sort="Mounier, N" uniqKey="Mounier N" first="N" last="Mounier">N. Mounier</name></region><name sortKey="Bachy, E" sort="Bachy, E" uniqKey="Bachy E" first="E" last="Bachy">E. Bachy</name><name sortKey="Bouadballah, R" sort="Bouadballah, R" uniqKey="Bouadballah R" first="R" last="Bouadballah">R. Bouadballah</name><name sortKey="Briere, J" sort="Briere, J" uniqKey="Briere J" first="J" last="Briere">J. Briere</name><name sortKey="Gisselbrecht, C" sort="Gisselbrecht, C" uniqKey="Gisselbrecht C" first="C" last="Gisselbrecht">C. Gisselbrecht</name><name sortKey="Ribrag, V" sort="Ribrag, V" uniqKey="Ribrag V" first="V" last="Ribrag">V. Ribrag</name><name sortKey="Thieblemont, C" sort="Thieblemont, C" uniqKey="Thieblemont C" first="C" last="Thieblemont">C. Thieblemont</name></country><country name="Australie"><noRegion><name sortKey="Gill, D" sort="Gill, D" uniqKey="Gill D" first="D" last="Gill">D. Gill</name></noRegion><name sortKey="Ma, D" sort="Ma, D" uniqKey="Ma D" first="D" last="Ma">D. Ma</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Linch, D" sort="Linch, D" uniqKey="Linch D" first="D" last="Linch">D. Linch</name></region><name sortKey="Radford, J" sort="Radford, J" uniqKey="Radford J" first="J" last="Radford">J. Radford</name></country><country name="République tchèque"><region name="Bohême centrale"><name sortKey="Trneny, M" sort="Trneny, M" uniqKey="Trneny M" first="M" last="Trneny">M. Trneny</name></region></country><country name="Suisse"><noRegion><name sortKey="Bargetzi, M" sort="Bargetzi, M" uniqKey="Bargetzi M" first="M" last="Bargetzi">M. Bargetzi</name></noRegion></country><country name="États-Unis"><region name="État de New York"><name sortKey="Moskowitz, C H" sort="Moskowitz, C H" uniqKey="Moskowitz C" first="C H" last="Moskowitz">C H Moskowitz</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B59 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003B59 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:27643872
|texte= Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:27643872" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |